FGF21 and metabolic dysfunction-associated steatotic liver disease: Other molecules which may play a role in the pathogenesis of CKD in MASLD are the hepatokines, in particular fibroblast growth factor-21 (FGF-21), whose levels increase in patients with type 2 diabetes mellitus [143], CKD [144] and NAFLD/MASLD [145].